22nd Century Group, Inc. (NASDAQ:XXII – Get Free Report) saw a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 91,500 shares, an increase of 1,933.3% from the December 31st total of 4,500 shares. Based on an average trading volume of 109,400 shares, the days-to-cover ratio is presently 0.8 days. Currently, 19.5% of the shares of the stock are sold short.
Institutional Investors Weigh In On 22nd Century Group
A hedge fund recently bought a new stake in 22nd Century Group stock. Anson Funds Management LP bought a new position in shares of 22nd Century Group, Inc. (NASDAQ:XXII – Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The fund bought 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned 6.77% of 22nd Century Group as of its most recent filing with the SEC. 18.06% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
XXII has been the subject of several analyst reports. StockNews.com downgraded shares of 22nd Century Group from a “hold” rating to a “sell” rating in a research note on Tuesday, December 31st. Weiss Ratings reissued a “sell (e+)” rating on shares of 22nd Century Group in a research report on Saturday, January 18th.
22nd Century Group Stock Down 6.3 %
22nd Century Group stock opened at $4.63 on Wednesday. The company has a current ratio of 1.09, a quick ratio of 0.93 and a debt-to-equity ratio of 1.59. The stock has a fifty day moving average price of $7.92 and a 200 day moving average price of $34.13. 22nd Century Group has a 52 week low of $3.90 and a 52 week high of $581.85.
22nd Century Group (NASDAQ:XXII – Get Free Report) last announced its quarterly earnings results on Tuesday, November 12th. The biotechnology company reported ($72.90) earnings per share for the quarter. The business had revenue of $5.95 million for the quarter.
About 22nd Century Group
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
Further Reading
- Five stocks we like better than 22nd Century Group
- How to Calculate Return on Investment (ROI)
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- 3 Warren Buffett Stocks to Buy Now
- What Does the Future Hold for Eli Lilly?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.